Evaxion Historical Balance Sheet
EVAX Stock | USD 1.14 0.05 4.20% |
Trend analysis of Evaxion Biotech AS balance sheet accounts such as Other Current Liabilities of 4.1 M or Total Current Liabilities of 5 M provides information on Evaxion Biotech's total assets, liabilities, and equity, which is the actual value of Evaxion Biotech AS to its prevalent stockholders. By breaking down trends over time using Evaxion Biotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Evaxion Biotech AS latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Evaxion Biotech AS is a good buy for the upcoming year.
Evaxion Biotech Inventory |
|
Evaxion |
About Evaxion Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Evaxion Biotech AS at a specified time, usually calculated after every quarter, six months, or one year. Evaxion Biotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Evaxion Biotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Evaxion currently owns. An asset can also be divided into two categories, current and non-current.
Evaxion Biotech Balance Sheet Chart
Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Evaxion Biotech balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Evaxion Biotech AS are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Evaxion Biotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Evaxion Biotech AS current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evaxion Biotech AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Evaxion Biotech's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to 140.70 in 2024, whereas Total Current Liabilities is likely to drop slightly above 5 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 1.0M | 1.2M | 3.9M | 4.1M | Short and Long Term Debt Total | 3.7M | 2.3M | 10.9M | 11.4M |
Evaxion Biotech balance sheet Correlations
Click cells to compare fundamentals
Evaxion Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Evaxion Biotech balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 11.1M | 12.0M | 40.2M | (58.9M) | 12.9M | 13.5M | |
Short Long Term Debt Total | 36K | 20K | 3.7M | 2.3M | 10.9M | 11.4M | |
Other Current Liab | 1.0M | 1.2M | 1.0M | 1.2M | 3.9M | 4.1M | |
Total Current Liabilities | 1.7M | 4.9M | 4.3M | 3.8M | 7.1M | 5.0M | |
Total Stockholder Equity | 9.4M | 7.0M | (50.4M) | (72.7M) | (4.7M) | (5.0M) | |
Property Plant And Equipment Net | 126K | 457K | 5.4M | 4.7M | 4.3M | 2.4M | |
Net Debt | (9.5M) | (5.8M) | (28.5M) | (10.9M) | 5.3M | 5.6M | |
Retained Earnings | (15.8M) | (27.3M) | (50.4M) | (72.7M) | (108.0M) | (102.6M) | |
Accounts Payable | 646K | 3.7M | 2.8M | 2.1M | 2.7M | 1.9M | |
Cash | 9.6M | 5.8M | 32.2M | 13.2M | 5.6M | 5.3M | |
Non Current Assets Total | 126K | 6.1M | 5.5M | 5.0M | 4.5M | 3.4M | |
Cash And Short Term Investments | 9.6M | 5.8M | 32.2M | 13.2M | 5.6M | 5.3M | |
Net Receivables | 931K | 1.8M | 1.9M | 789K | 1.1M | 1.1M | |
Liabilities And Stockholders Equity | 11.1M | 12.0M | (42.7M) | (58.9M) | 12.9M | 13.5M | |
Non Current Liabilities Total | 682K | 2.7M | 3.4M | 10.0M | 10.5M | 11.1M | |
Capital Lease Obligations | 36K | 20K | 2.5M | 2.3M | 2.2M | 1.1M | |
Other Current Assets | 468.0K | 6.3M | 3.2M | 2.5M | 1.7M | 2.3M | |
Total Liab | 1.7M | 4.9M | 7.7M | 13.7M | 17.6M | 18.5M | |
Net Invested Capital | 9.4M | 7.0M | 33.6M | 16.3M | 3.9M | 3.7M | |
Total Current Assets | 11.0M | 5.8M | 34.7M | 14.0M | 8.4M | 13.3M | |
Accumulated Other Comprehensive Income | 22.7M | 31.7M | 79.1M | (3.7M) | (3.8M) | (3.6M) | |
Net Working Capital | 9.2M | 6.0M | 30.4M | 13.2M | 1.3M | 1.2M | |
Short Term Debt | 36K | 40K | 440K | 439K | 485K | 460.8K | |
Common Stock | 2.5M | 2.6M | 3.8M | 3.9M | 5.9M | 3.6M | |
Other Assets | 25K | 694K | 191K | (78.0M) | 134.0 | 140.7 | |
Inventory | (6.0) | (6.9M) | (1.9M) | (2.5M) | (2.2M) | (2.4M) | |
Other Stockholder Equity | (169K) | 34.3M | (82.9M) | 80.7M | 101.1M | 106.2M | |
Capital Stock | 2.5M | 2.6M | 3.8M | 3.9M | 5.9M | 3.8M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Evaxion Stock Analysis
When running Evaxion Biotech's price analysis, check to measure Evaxion Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evaxion Biotech is operating at the current time. Most of Evaxion Biotech's value examination focuses on studying past and present price action to predict the probability of Evaxion Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evaxion Biotech's price. Additionally, you may evaluate how the addition of Evaxion Biotech to your portfolios can decrease your overall portfolio volatility.